Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
7(41%)
Results Posted
40%(2 trials)
Terminated
1(6%)

Phase Distribution

Ph phase_4
3
18%
Ph phase_2
2
12%
Ph not_applicable
7
41%
Ph phase_1
1
6%

Phase Distribution

1

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
1(7.7%)
Phase 2Efficacy & side effects
2(15.4%)
Phase 4Post-market surveillance
3(23.1%)
N/ANon-phased studies
7(53.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

7

trials recruiting

Total Trials

17

all time

Status Distribution
Active(10)
Completed(5)
Terminated(1)
Other(1)

Detailed Status

Completed5
Recruiting4
Active, not recruiting3
Not yet recruiting2
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
7
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (7.7%)
Phase 22 (15.4%)
Phase 43 (23.1%)
N/A7 (53.8%)

Trials by Status

recruiting424%
unknown16%
not_yet_recruiting212%
terminated16%
active_not_recruiting318%
completed529%
enrolling_by_invitation16%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT03926520Not Applicable

Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD)

Recruiting
NCT05306184

Prospective Assessment of Cost-effectiveness and Side-effects of Depressive Patients Treated With ECT or TCA

Active Not Recruiting
NCT07498387Not Applicable

Management of Catatonic Features in Adolescents With Profound Autism

Active Not Recruiting
NCT07463911

Treatment Response In ECT Patients

Active Not Recruiting
NCT04480918

University of Iowa Interventional Psychiatry Service Patient Registry

Recruiting
NCT07418463

Effects of Repeated Electroconvulsive Therapy Sessions on Anesthetic Requirements

Not Yet Recruiting
NCT06672588Not Applicable

Magnetic Seizure Therapy for Schizophrenia - Trial

Recruiting
NCT06034821Phase 4

Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan

Enrolling By Invitation
NCT04080778Not Applicable

Magnetic Seizure Therapy in Bipolar Depression (MST-BpD) and Treatment Resistant Depression (MST-TRD)

Recruiting
NCT04441008Not Applicable

Accelerated iTBS for Depression and Suicidality

Not Yet Recruiting
NCT03641300Not Applicable

Efficacy of Convulsive Therapies for Bipolar Depression

Completed
NCT03113968Phase 2

ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)

Completed
NCT03980366Not Applicable

Use of Electroconvulsive Therapy to Treat Self-Injurious Behavior in Adults With Autism Spectrum Disorders

Terminated
NCT00042224Phase 1

Electroconvulsive Therapy in Clozapine Refractory Schizophrenia

Completed
NCT02924090Phase 4

Hyperventilation Combined With Etomidate or Ketamine Anesthesia in ECT Treatment of Major Depression

Unknown
NCT00487500Phase 4

Comparing the Effects of Four Types of Electroconvulsive Therapy on Mood and Thinking in People With Depression

Completed
NCT00299403Phase 2

The Antidepressant Effect of Repetitive Transcranial Magnetic Stimulation (rTMS)Compared to ECT

Completed

All 17 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
17